Fontolizumab Protein Design Labs.
Article Details
- CitationCopy to clipboard
Dumont FJ
Fontolizumab Protein Design Labs.
Curr Opin Investig Drugs. 2005 May;6(5):537-44.
- PubMed ID
- 15912969 [ View in PubMed]
- Abstract
Protein Design Labs is developing fontolizumab, a humanized anti-interferon gamma monoclonal antibody, for the potential treatment of autoimmune diseases. By February 2003, the company was actively seeking to outlicense the development and commercialization rights to fontolizumab outside of the US and Canada.
DrugBank Data that Cites this Article
- Drugs